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Abstract
Background: Animal and cell culture data suggest a critical role for Munc18c and Syntaxin 4
proteins in insulin mediated glucose transport in skeletal muscle, but no studies have been
published in humans.
Methods: We investigated the effect of a 12 vs. 48 hr fast on insulin action and skeletal muscle
Munc18c and Syntaxin 4 protein in lean and obese subjects. Healthy lean (n = 14; age = 28.0 +/- 1.4
yr; BMI = 22.8 +/- 0.42 kg/m2) and obese subjects (n = 11; age = 34.6 +/- 2.3 yr; BMI = 36.1 +/- 1.5
kg/m2) were studied twice following a 12 and 48 hr fast. Skeletal muscle biopsies were obtained
before a 3 hr 40 mU/m2/min hyperinsulinemic-euglycemic clamp with [6,6-2H2]glucose infusion.
Results: Glucose rate of disappearance (Rd) during the clamp was lower in obese vs. lean subjects
after the 12 hr fast (obese: 6.25 +/- 0.67 vs. lean: 9.42 +/- 1.1 mg/kgFFM/min, p = 0.007), and
decreased significantly in both groups after the 48 hr fast (obese 3.49 +/- 0.31 vs. lean: 3.91 +/- 0.42
mg/kgFFM/min, p = 0.002). Munc18c content was not significantly different between lean and obese
subjects after the 12 hour fast, and decreased after the 48 hr fast in both groups (p = 0.013).
Syntaxin 4 content was not altered by obesity or fasting duration. There was a strong positive
relationship between plasma glucose concentration and Munc18c content in lean and obese
subjects during both 12 and 48 hr fasts (R2 = 0.447, p = 0.0015). Significant negative relationships
were also found between Munc18c and FFA (p = 0.041), beta-hydroxybutyrate (p = 0.039), and
skeletal muscle AKT content (p = 0.035) in lean and obese subjects.
Conclusion: These data indicate Munc18c and Syntaxin 4 are present in human skeletal muscle.
Munc18c content was not significantly different between lean and obese subjects, and is therefore
unlikely to explain obesity-induced insulin resistance. Munc18c content decreased after prolonged
fasting in lean and obese subjects concurrently with reduced insulin action. These data suggest
changes in Munc18c content in skeletal muscle are associated with short-term changes in insulin
action in humans.
Introduction
Insulin resistance is commonly observed in obese
humans. Defects in skeletal muscle insulin signaling have
been extensively studied, and much is now known about
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obesity and Type 2 diabetes which can help explain insu-
lin resistance in these populations. However, the role of
alterations in GLUT4 vesicle tethering, docking, and
fusion to the plasma membrane in causing insulin resist-
ance is not clear.
Increasing evidence suggests GLUT4 vesicle fusion to the
sarcolemma is under tight regulation by the coordinated
action of soluble N-ethylmaleimide-sensitive factor
attachment protein receptors (SNARE's) on both the
GLUT4 vesicle (v-SNARE's) and the inner surface of the
target plasma membrane (t-SNARE's) [1]. Vesicle associ-
ated membrane protein 2 (VAMP2) is a v-SNARE interact-
ing with Syntaxin 4 in the docking step of GLUT4
translocation. Munc18c modulates interactions required
for vesicle fusion [1] and is thought to bind to Syntaxin 4
which prevents interaction with VAMP2 [2], although
other models have been proposed [3,4]. Insulin binding
to the sarcolemma may remove inhibition of Munc18c
either through dissociation or repositioning [5], promot-
ing Syntaxin 4 and VAMP2 interaction, allowing GLUT4
vesicle fusion to the plasma membrane [6].
Animal data suggest a critical role played by the relative
proportion of Munc18c and Syntaxin 4 proteins in skele-
tal muscle. Over expression of Munc18c relative to Syn-
taxin 4 in skeletal muscle leads to insulin resistance [7,8].
Heterozygous knockout of Syntaxin 4 in mice also results
in insulin resistance [9]. Importantly, Spurlin et al. found
that the relative abundance of Munc18c/Syntaxin 4 was
more influential than the absolute protein content on
whole body glucose disposal in transgenic mice [7]. These
results have been corroborated in 3T3L1 adipocyte mod-
els where increased expression of Munc18c decreased
insulin action [6,10-12], or microinjection of Munc18c
antibodies to decrease cellular content increased insulin
action [11]. No published investigations have examined
the potential importance of Munc18c and Syntaxin 4 in
human muscle. This study was designed to determine if
Munc18c and Syntaxin 4 are present in human skeletal
muscle. We tested if the amount of Munc18c and Syntaxin
4 in skeletal muscle differ in obese and lean humans, and
if the relative expression changes in response to the acute
induction of insulin resistance via fasting.
Methods
Subjects
Healthy, sedentary, lean men and women and non-dia-
betic obese men and women with normal glucose toler-
ance who were weight stable for at least 6 months were
recruited for this study (Table 1). Women were taking oral
contraceptives and were studied in the week they were not
taking the active pill. This study was approved by the
Colorado Multiple Institution Review Board at the Uni-
versity of Colorado Denver and Health Sciences Center.
Diet and Fasting
A standardized diet containing 30% fat, 15% protein, and
55% carbohydrate was provided to each subject for 3 days
prior to both metabolic studies which were separated by
1–2 months. Subjects remained resident on the General
Clinical Research Center (GCRC) during the 12 and 48
hour fasts which were completed in random order. A strict
fast was imposed where subjects were only allowed to
consume water, ice, and flavored non-caloric carbonated
water.
Metabolic Studies
In the morning after completion of the 12 or 48 hr fast, a
baseline blood sample was drawn followed by a primed
(4.5 mg/kg) constant (0.03 mg/kg/min) infusion of [6,6-
2H2]glucose. Following two hours of rest and blood sam-
pling, a vastus lateralis muscle biopsy was performed
using the Bergstrom needle technique [13]. The muscle
biopsies were taken from midway between the greater tro-
chanter of the femur and the patella. The anatomic loca-
Table 1: Subject Characteristics
Lean Obese
N (M/W) (7/7) (5/6)
Age (yrs) 28 ± 1.4 34.6 ± 2.3§
Weight (kg) 68.2 ± 3.0 102.7 ± 3.5§
Height (in) 69 ± 1.3 68.3 ± 1.4
BMI (kg/m2) 22.8 ± 0.4 35.4 ± 1.3§
% Body Fat 24.5 ± 2.3 42.3 ± 2.5§
Waist Circumference (in) 33.2 ± 1.1 44.1 ± 1.4§
Fasting Glucose (mg/dl) 84.2 ± 1.5 90.1 ± 2.2§
Fasting Insulin (uU/ml) 5.5 ± 0.6 8.3 ± 1.4
2 hour OGTT glucose (mg/dl) 95.6 ± 9.1 120.5 ± 8.1§
12 hr clamp glucose Rd (mg/kg FFM/min) 9.42 ± 1.1 6.25 ± 0.67§
48 hr clamp glucose Rd (mg/kg FFM/min) 3.91 ± 0.42# 3.49 ± 0.31#
Values are means ± SEM. § = significantly different than lean (p < 0.05), # = significantly different than 12 hr (p < 0.05).Nutrition & Metabolism 2008, 5:21 http://www.nutritionandmetabolism.com/content/5/1/21
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tion and depth of the biopsy was as similar as possible
between subjects to minimize variation in muscle fiber
composition which varies along the depth and length of
the vastus lateralis [14]. During the repeat study, the con-
tralateral leg was used for the muscle biopsy. A hyperin-
sulinemic-euglycemic clamp was initiated using a
descending prime of insulin with a continuous infusion at
40 mU/m2/min and was continued for the next 3 hours
using the method of DeFronzo et al. [15].
Tissue Processing
Frozen skeletal muscle samples were weighed, and
homogenized on ice using a Kontes glass homogenizer
(Kimble/Kontes, Vineland, NJ) in buffer containing 20
mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% IPEGAL, 20 mM
NaF,2 mM EDTA, pH 8.0, 2.5 mM NaPP, 20 mM β-Glyc-
ero-PO4, 10% glycerol, as well as protease (Roche Applied
Science, Indianapolis, IN) and phosphatase inhibitors
(Sigma, Saint Louis, MO). Samples were agitated at 4°C
for 1 hour, then spun at 16,000 g for 15' to pellet insolu-
ble protein. Supernatant was saved, and used to deter-
mine protein concentration (Pierce, Rockford, IL).
Western Blotting
Fifty μg of standard, sample protein, and internal standard
were run on an SDS-PAGE 4–15% Tris-HCl gel (BioRad,
Hercules, CA), transferred to a PVDF membrane, and
blocked with 5% nonfat milk or BSA for 1 hour at room
temperature. Primary antibody incubations were per-
formed in 5% nonfat milk or BSA overnight at 4°C, and
an HRP conjugated secondary antibody was incubated for
1 hour at room temperature. Enhanced chemilumines-
cence was used to visualize protein bands of interest.
Intensity of protein bands was captured using an
AlphaImager 3300 (Alpha Innotech Corp, San Leandro,
CA) and quantified using FluorChem software (Alpha
Innotech Corp, San Leandro, CA). Protein bands were
normalized to GAPDH as a loading control, and then nor-
malized to an internal standard which was run on every
gel. Rabbit anti-Munc18c antibodies were a generous gift
from Dr. David James, mouse anti-Syntaxin 4 antibodies
were purchased from BD Transduction Laboratories (BD
Biosciences, Mississauga, ON Canada), GAPDH antibod-
ies were purchased from Santa Cruz Biotechnology (Santa
Cruz Biotechnology, Santa Cruz, CA) and secondary anti-
bodies from Chemicon (Chemicon International Inc,
Temecula, CA).
Gas chromatography/mass spectroscopy methods
Glucose isotopic enrichment was measured with the
penta-acetate derivative of glucose using standard GC/MS
methodology (5890 GC, 5989 MS, Hewlett-Packard)
[16,17]. Rates of glucose disappearance (Rd) during the
clamp were calculated using a modified Steele equation
described by Finegood, et al [18].
Statistics
Data are presented as mean ± SEM. After the 12 hour fast,
muscle biopsies from 9 lean subjects and 6 obese subjects
were analyzed, while after the 48 hour fast muscle biop-
sies from 7 lean subjects and 6 obese subjects were ana-
lyzed. Differences between fasting duration and lean and
obese groups were analyzed using repeated measures
ANOVA with one 2-level within subject factor (12 vs. 48
hr fast), and one 2-level between subjects factor (lean vs.
obese) (JMP statistical software, Cary, NC). An alpha level
of 0.05 was used throughout. Since this is the first report
of Munc18c and Syntaxin 4 in skeletal muscle, we are
reporting all correlations significant at the alpha 0.05 level
without correcting for multiple comparisons. Correla-
tions were performed to all the metabolic and insulin sig-
naling variables measured in the parent study [16], and
the significant relationships reported here. We hope this
promotes hypothesis formation, furthering research in
this area.
Results
Subject Characteristics
Anthropometric data for subjects are reported in Table 1.
Outcome variables were similar between genders, so men
and women were combined and data are reported as lean
and obese only. Per design, lean subjects weighed signifi-
cantly less (p < 0.05), and had a lower BMI, % body fat,
and waist circumference than obese (p < 0.05).
Insulin Clamp
Data on insulin sensitivity in these subjects has previously
been published [16]. Insulin stimulated glucose Rd was
significantly greater in lean compared to obese subjects
after the 12 hour fast (Table 1). After the 48 hour fast insu-
lin stimulated glucose Rd was significantly lower than the
12 hour fast in lean and obese subjects (p < 0.001). The
decrease in glucose Rd from the 12 to 48 hour clamp
tended to be greater (p = 0.059) in lean (58%) compared
to obese subjects (44%).
Munc18c and Syntaxin 4 Protein Content
No significant differences were observed for Munc18c
content in skeletal muscle between lean and obese sub-
jects after 12 or 48 hour fasts (Figure 1A). Munc18c con-
tent decreased in the lean and obese subjects after the 48
as compared to the 12 hour fast (p = 0.013, Figure 1A).
Syntaxin 4 content was not different between lean and
obese subjects, and did not significantly change after 48
compared to 12 hours of fasting (Figure 2A).
There was a strong significant positive relationship
between plasma glucose concentration and muscle
Munc18c content in lean and obese subjects following
both 12 and 48 hr fasts (R2 = 0.45, p = 0.002, Figure 3A).
Several other relationships were discovered including sig-Nutrition & Metabolism 2008, 5:21 http://www.nutritionandmetabolism.com/content/5/1/21
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nificant negative correlations between muscle Munc18c
and plasma FFA (Figure 3B, R2 = 0.13, p = 0.04), serum
beta hydroxybutyrate (Figure 3C, R2 = 0.14, p = 0.04), and
total muscle AKT content (Figure 3D, R2 = 0.15, p = 0.04).
Relationships were not significant between muscle
Munc18c and serum insulin concentration (p = 0.22), adi-
ponectin (p = 0.63), leptin (p = 0.43), glucose disposal
during the euglycemic insulin clamp (p = 0.15), muscle
insulin receptor phosphotyrosine content (p = 0.09),
serine307 phosphorylation of IRS-1/total IRS-1 (p =
0.11), and pan85 content (p = 0.11)
Discussion
This is the first study to report tissue Munc18c, and Syn-
taxin 4 protein content in humans. We found no signifi-
cant differences in the content of either protein in obese
compared to lean subjects after an overnight fast (Figures
1 and 2). Therefore, these data suggest insulin resistance
associated with obesity in humans is not explained by
constitutive differences in skeletal muscle Munc18c and
Syntaxin 4 content.
Prolonged fasting induced a significant decrease in glu-
cose uptake during the clamp in lean and obese subjects
after the 48 compared to the 12 hour fast (Table 1). Fast-
ing for 48 hours did not change Syntaxin 4 (Figure 2), but
significantly decreased Munc18c content in lean and
obese subjects (Figure 1). These data suggest prolonged
fasting decreased basal skeletal muscle Munc18c content
regardless of body type, which may be one mechanism by
which fasting decreased insulin stimulated glucose
uptake.
The optimum amount of skeletal muscle Munc18c to pro-
mote GLUT4 vesicle fusion is not known. However, it has
been demonstrated that deletion of the Munc18c gene is
A) Syntaxin 4 content after 12 and 48 hours of fasting in the  basal state in lean and obese subjects, B) Representative blot  for Syntaxin 4 in lean and obese subjects Figure 2
A) Syntaxin 4 content after 12 and 48 hours of fasting 
in the basal state in lean and obese subjects, B) Rep-
resentative blot for Syntaxin 4 in lean and obese sub-
jects. Values are means ± SEM.
A) Munc18c content after 12 and 48 hours of fasting in lean  and obese subjects, B) Representative blot for Munc18c in  lean and obese subjects Figure 1
A) Munc18c content after 12 and 48 hours of fasting 
in lean and obese subjects, B) Representative blot for 
Munc18c in lean and obese subjects. Values are means ± 
SEM. # = significantly different than 12 hr (p < 0.05).Nutrition & Metabolism 2008, 5:21 http://www.nutritionandmetabolism.com/content/5/1/21
Page 5 of 7
(page number not for citation purposes)
lethal [19], and that too little or too much Munc18c can
alter insulin sensitivity in animals [7-9,20], and cell cul-
ture [6,10-12]. Further, the content of Munc18c relative to
Syntaxin 4 appears more important than the absolute con-
tent of each on whole body glucose disposal in mice [7].
This study elaborates on previous data and suggests that
Munc18c, and not Syntaxin 4, appears to be the regulated
of these two proteins in human skeletal muscle.
We have previously reported increased Munc18c with no
change in Syntaxin 4 content in mice over expressing skel-
etal muscle lipoprotein lipase [20] which correlated with
decreased insulin action following high fat feeding. The
Relationships between skeletal muscle Munc18c content and A) plasma glucose (R2 = 045, p = 0.002) B) plasma FFA (R2 = 0.13,  p = 0.04) C) plasma beta-hydroxybutyrate (R2 = 0.14, p = 0.04) and D) skeletal muscle AKT content (R2 = 0.15, p = 0.04) and  in lean and obese men and women after 12 and 48 hours of fasting Figure 3
Relationships between skeletal muscle Munc18c content and A) plasma glucose (R2 = 0.45, p = 0.002) B) 
plasma FFA (R2 = 0.13, p = 0.04) C) plasma beta-hydroxybutyrate (R2 = 0.14, p = 0.04) and D) skeletal muscle 
AKT content (R2 = 0.15, p = 0.04) and in lean and obese men and women after 12 and 48 hours of fasting.Nutrition & Metabolism 2008, 5:21 http://www.nutritionandmetabolism.com/content/5/1/21
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current data are different from that found in rodents, as
both Munc18c and Syntaxin 4 content were unchanged in
obese compared to lean humans after an overnight fast
despite significant differences in glucose Rd during the
clamp.
Moreover, our data demonstrating decreased skeletal
muscle Munc18c content after a 48 hour fast are not what
was expected from the animal literature where tissue
Munc18c content is negatively related to insulin action
[6,9-11]. Therefore, it is possible that decreased Munc18c
is a compensatory response to maintain insulin action
during a prolonged fast. These discrepancies in data in
humans vs. mice suggest a species difference in the regula-
tion of Munc18c.
Basal Syntaxin 4 content was not significantly different
between lean and obese subjects after 12 and 48 hours of
fasting. In mice, decreased Syntaxin 4 content has been
associated with insulin resistance during a clamp [9] and
following streptozotocin-induced diabetes [21]. Our data
differ from animal studies and suggest Syntaxin 4 content
may not be involved in short-term regulation of insulin
action in humans, and may not be important to obesity-
induced insulin resistance.
We found a significant relationship between plasma glu-
cose concentration and Munc18c content (Figure 3A, p =
0.0015) in lean and obese subjects after 12 and 48 hr fasts.
Whether glucose concentration influences Munc18c con-
tent or vice versa remains to be determined. However, our
data indicate close regulation between these 2 parameters.
In the fasting state FFA and beta-hydroxybutyrate concen-
trations change dramatically, and could reduce by an
unknown mechanism the Munc18c content of skeletal
muscle. Another possible explanation is that alterations in
the expression of muscle Munc18c may promote changes
in glucose concentration and skeletal muscle AKT content.
Animal data suggest that Munc18c may promote insulin
resistance [6,9-11]. The relationship between plasma glu-
cose concentration and skeletal muscle Munc18c in this
study is consistent with this idea. If Munc18c influences
glucose concentration, what else besides FFA and beta-
hydroxybutyrate drives changes in Munc18c content? Pre-
vious data from our laboratory indicated skeletal muscle
LPL overexpression in mice increased Munc18c and intra-
muscular triglyceride content, along with a decrease in
insulin action [20]. These animal data suggest increased
storage of intramuscular triglyceride in muscle may be
related to increased Munc18c content. In hindsight, meas-
urement of intramuscular triglyceride concentration
would have been informative in this study to determine if
there is a relationship with muscle Munc18c content.
The significant relationships between glucose (Figure 3A),
FFA (Figure 3B) and beta-hydroxybutyrate concentration
(Figure 3C) suggest there are potential associations
between plasma substrates and muscle Munc18c. The sig-
nificant negative relationship between Munc18c and AKT
content in skeletal muscle biopsies (Figure 3D) could
indicate that increased Munc18c expression in skeletal
muscle may be related to decreased AKT content, and pro-
mote insulin resistance. The relationship between
Munc18c and AKT is somewhat puzzling because a
decrease in Munc18c with fasting (Figure 1) corresponded
to decreased insulin action (Table 1) as well as an increase
in AKT content. However, we did not find a significant
change in the phosphorylation of AKT relative to the total
content, suggesting that the change in total content was
not related to activity. Further, it is possible that both
Munc18c and AKT content were altered in response to
other signals, and that the change in one does not pro-
mote a change in the other. This study was not designed
to test relationships between Munc18c and metabolic or
insulin signaling variables. However, these relationships
are intriguing and suggest that the content of Munc18c
changes in parallel with blood metabolites and the insu-
lin signaling cascade.
We are hesitant to discuss non-significant relationships,
but given that this is the first report of Munc18c and Syn-
taxin 4 in humans, we feel obligated to show all data that
may move the field forward if further studied. We did not
find significant relationships between Munc18c and insu-
lin concentration (p = 0.22), as well as the adipokines adi-
ponectin (p = 0.63), and leptin (p = 0.43) which are
thought to modulate insulin action [22]. We found sev-
eral interesting, but non-significant negative relationships
between Munc18c and glucose disposal during the insulin
clamp (p = 0.15), and insulin signaling including insulin
receptor phosphotyrosine content (p = 0.085), serine307
phosphorylation of IRS-1/total IRS-1 (p = 0.11), and
pan85 content (p = 0.11). Given that there was a signifi-
cant relationship between Munc18c and AKT content,
these data suggest that there may be concurrent regulation
of Munc18c and the insulin signaling cascade.
Conclusion
These are the first data reporting Munc18c and Syntaxin 4
protein content in humans. No significant differences
were observed for Munc18c and Syntaxin 4 content in
lean and obese human skeletal muscle after 12 or 48
hours of fasting. However, along with a significant
decrease in insulin sensitivity, Munc18c content
decreased in lean and obese subjects after the 48 hour fast
suggesting these two parameters may be related. We also
found significant relationships between skeletal muscle
AKT content, plasma glucose, FFA, and beta-hydroxybu-
tyrate concentration and skeletal muscle Munc18c. ThesePublish with BioMed Central    and   every 
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data suggest Munc18c is under short-term regulation and
may influence insulin action in humans.
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